Neuble AI Raises $269K Seed

Neuble AI, a Seoul-based medtech startup developing AI-based diagnostic and analysis solutions for brain diseases, has raised $269,000 in seed funding. The company, which specializes in medical imaging AI, aims to improve diagnostic precision and accessibility for degenerative brain conditions like dementia.

Investors

This round was led by Futureplay, an investment firm that focuses on deep tech and early-stage ventures.

Neuble AI Use of Funds

The newly raised capital will support regulatory submissions to South Korea's Ministry of Food and Drug Safety (MFDS), the U.S. Food and Drug Administration (FDA), and the European CE marking process ahead of BrainCura's commercial launch.

About Neuble AI

Founded by clinical faculty from Gangnam Severance Hospital, including radiologists and medical physicists, Neuble AI develops diagnostic support tools that combine clinical experience with medical imaging technology. Its product pipeline includes BrainCura, an AI tool for volumetric brain measurement via CT scans, and SynCura, which synthesizes MRI-quality images from CT scans.

Funding Details

Company Website: https://neubleai.com

Company: Neuble AI
Raised: $269K
Round: Seed
Funding Date: July 16, 2026
Lead Investor: Futureplay
Software Category: Medical AI
Source: https://en.wowtale.net/2026/07/16/234484/